Uncommon ALK fusion partners in advanced ALK-positive non-small-cell lung cancer.

Jin Kang,X. Zhang,Hua-Jun Chen,Qing Zhou,Hai-Yan Tu,Wen-Feng Li,Yi-Long Wu,Jin-Ji Yang

Uncommon ALK fusion partners in advanced ALK-positive non-small-cell lung cancer.

2018

Jin Kang
X. Zhang
Hua-Jun Chen
Qing Zhou
Hai-Yan Tu
Wen-Feng Li
Yi-Long Wu
Jin-Ji Yang

8561Background: The variants affect the efficacy of crizotinib in echinoderm microtubule protein-like-4 (EML4)- anaplastic lymphoma kinase (ALK) fusion-positive non–small-cell lung cancers (NSCLCs)...

Keywords:

ALK-Positive
Cell
Cancer research
Pathology
Lung cancer
Medicine
non small cell
Anaplastic lymphoma kinase
Crizotinib
Lung

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations